Welcome to our dedicated page for WNNR.U news (Ticker: WNNR.U), a resource for investors and traders seeking the latest updates and insights on WNNR.U stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect WNNR.U's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of WNNR.U's position in the market.
Andretti Acquisition Corp. announced the pricing of its initial public offering (IPO) of 20 million units at $10.00 each, to be listed on the NYSE under the symbol 'WNNR.U' starting January 13, 2022. Each unit includes one Class A ordinary share and a half warrant, with whole warrants exercisable at $11.50 per share. The offering is set to close on January 18, 2022, pending standard conditions. RBC Capital Markets is the sole book-running manager and has a 45-day option for an additional 3 million units. The registration statement was declared effective by the SEC on January 12, 2022.
